Tag: Lipiodol

Automatic characterisation of Lipiodol deposition after cTACE may make predictions about...

Automatic characterisation of Lipiodol (Guerbet) deposition is feasible, workflow efficient, and improves consistency across patients, argued Sophie Stark (Yale School of Medicine, New Haven,...

New indication approved for Guerbet’s Lipiodol Ultra Fluid

A new indication for Lipiodol Ultra Fluid (Guerbet) has been approved in Switzerland and in India for chemoembolization (cTACE) of tumours in adults with...

Artificial intelligence will support clinical decision making in interventional oncology

Aaron Abajian and Julius Chapiro, New Haven, USA, write about results from an early experiment in applying artificial intelligence (AI) and machine learning as a...

German Federal Institute for Drugs and Medical Devices approves new indication...

Guerbet has announced that the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; The German Federal Institute for Drugs and Medical Devices) has now approved Lipiodol...

Thailand FDA approves new indication for Guerbet’s Lipiodol Ultra-Fluide

Guerbet has announced that the Thailand FDA has given approval of a new indication for Lipiodol Ultra-Fluide for selective hepatic intra-arterial injection for visualisation,...

Guerbet expands distribution partnership in Canada with Methapharm

Guerbet has announced that as of 1 February 2017, Methapharm will promote and distribute all Guerbet products in Canada. "As a result of our excellent...